Lundbeck
HLUN-B.CO
#2605
Rank
HK$50.96 B
Marketcap
HK$53.70
Share price
-0.32%
Change (1 day)
15.81%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2025 (TTM): HK$6.66 Billion

According to Lundbeck's latest financial reports the company's current earnings are HK$3.61 Billion. In 2024 the company made an earning of HK$4.30 Billion, an increase over its 2023 earnings that were of HK$3.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$6.66 B54.59%
2024 HK$4.30 B25.74%
2023 HK$3.42 B21.77%
2022 HK$2.81 B31.57%
2021 HK$2.13 B-4.61%
2020 HK$2.24 B-45.06%
2019 HK$4.08 B-34.04%
2018 HK$6.18 B12.83%
2017 HK$5.48 B93.99%
2016 HK$2.82 B-137.28%
2015 -HK$7.59 Billion-1246.24%
2014 HK$0.66 B-72.36%
2013 HK$2.39 B4.38%
2012 HK$2.29 B-55.18%
2011 HK$5.11 B5.65%
2010 HK$4.84 B-5.9%
2009 HK$5.14 B